Bafna Pharmaceuticals Limited

NSE BAFNAPH.NS

Bafna Pharmaceuticals Limited Market Capitalization on February 07, 2025: USD 21.71 M

Bafna Pharmaceuticals Limited Market Capitalization is USD 21.71 M on February 07, 2025, a -27.46% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Bafna Pharmaceuticals Limited 52-week high Market Capitalization is USD 32.81 M on May 06, 2024, which is 51.09% above the current Market Capitalization.
Bafna Pharmaceuticals Limited 52-week low Market Capitalization is USD 21.13 M on February 05, 2025, which is -2.71% below the current Market Capitalization.
Bafna Pharmaceuticals Limited average Market Capitalization for the last 52 weeks is USD 24.67 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NSE: BAFNAPH.NS

Bafna Pharmaceuticals Limited

CEO	Mr. Bansilal Mahaveer Chand Bafna
IPO Date	Nov. 12, 2012
Location	India
Headquarters	Bafna Towers
Employees	363
Sector	Healthcare
Industries Pharmaceuticals 3D Printing Cleaning Supplies Composite Materials Cosmetics Drugstores & Retail Pharmacies Glass Plastics

Description

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.

Key trends

Past 5 years